Trospium Chloride
Product Images NDC 69150-258

7 FDA label images from Biomes Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Trospium Chloride (NDC 69150-258). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biomes Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A pharmacokinetic line graph showing plasma concentration (ng/mL) on the vertical axis versus time (hours post-dose) on the horizontal axis, ranging from 0 to 48 hours. The graph displays plasma levels of Trospium Chloride peaking around 2-4 hours post-dose and gradually declining over time, with error bars indicating variability at each time point.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A line graph comparing mean changes over treatment weeks between placebo and Trospium chloride groups. The x-axis represents weeks of treatment (1, 4, 12), and the y-axis shows mean change with standard error. Trospium chloride group shows greater mean change decline over time compared to placebo, with p-values indicating statistical significance at weeks 4 and 12.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A line graph comparing mean change over 12 weeks of treatment between placebo and Trospium chloride groups. The x-axis represents the week of treatment (1, 4, 12), and the y-axis shows the mean change with standard error. Placebo group is shown with a dashed line and open circles, Trospium chloride group with a solid line and filled circles, including sample sizes and p-values at each time point.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
A line graph comparing the mean change over time between Trospium chloride and placebo groups across 12 weeks of treatment. The x-axis represents the week of treatment (1, 4, 12), and the y-axis shows mean change with standard error. Trospium chloride demonstrates a greater decrease than placebo, with statistical significance indicated at each time point.*
FDA Label Image

Figure 5 (Figure 5)

Figure 5 (Figure 5)
A line graph showing mean (± standard error) change over treatment weeks comparing Trospium Chloride and placebo. The x-axis represents weeks of treatment (1, 4, and 12), and the y-axis shows mean change values. Two lines depict data for placebo (N=325) and Trospium Chloride (N=323), with Trospium Chloride showing greater mean change at all time points, along with p-values indicating statistical significance (p<0.001).*
FDA Label Image

Label (Label)

Label (Label)
Trospium Chloride 20 mg tablet label from BIOMES Pharmaceuticals LLC, featuring a bottle containing 60 tablets. The label includes dosage strength, NDC 69150-258-06, storage instructions, and dispensing guidance for pharmacists. It also displays the lot number and expiration date boxes.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Trospium Chloride, showing its molecular composition including a quaternary ammonium group with a chloride ion, a bicyclic ring system, an ester bond, and two phenyl rings attached to a carbon bearing a hydroxyl group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.